Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

AM-425 available for licensing

Oct. 25, 1996

PRIMATIZED monoclonal antibody proven safe and effective for rheumatoid arthritis

Oct. 25, 1996

Sulfasalazine approved for rheumatoid arthritis

Oct. 25, 1996

NIH seeks licensees for antigenic MMP peptides with potential as therapeutic and diagnostic agents

Oct. 25, 1996

MMP/TNF production inhibitors reported by Pfizer

Oct. 25, 1996

Dimethaid seeks approval for treatment for arthritic pain

Oct. 18, 1996

Washington University's MCP regulates complement activity

Oct. 18, 1996

New cPLA2 inhibitor from Merckle

Oct. 18, 1996

University of North Carolina/Macronex research cytokine inhibitors

Oct. 18, 1996

Important milestone for Connective Therapeutics' ConXn

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...